Weight and height changes and factors associated with greater weight and height gains after pediatric renal

Bethany J Foster1, Karen Martz, Manjula Gowrishankar

  • 1Division of Nephrology, Montreal Children's Hospital, McGill University, Montreal, QC, Canada. beth.foster@muhc.mcgill.ca

Transplantation
|February 20, 2010
PubMed

Insights

Pediatric kidney transplant recipients often experience significant early increases in body mass index (BMI) percentiles, which tend to persist for years. Certain factors like age, sex, race, ethnicity, and corticosteroid use influence these adiposity changes.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology
  • Growth and Development

Background:

  • Obesity is a critical concern in pediatric kidney transplant patients.
  • Understanding post-transplant adiposity changes is crucial for long-term outcomes.

Purpose of the Study:

  • To analyze changes in adiposity (body mass index percentiles) after pediatric renal transplantation.
  • To identify risk factors associated with increased adiposity within 12 months and its persistence at 48 months.
  • To examine changes in height-for-age post-transplantation.

Main Methods:

  • Retrospective cohort study using the North American Pediatric Renal Trials and Collaborative Studies registry.
  • Inclusion of children aged 2-18 years transplanted between 1995 and 2006, with follow-up to January 2007.
  • Multivariable linear regression to identify risk factors for adiposity and height changes.

Main Results:

  • Median body mass index percentile (BMI%) increased by 11.37 units within 6 months post-transplant, with sustained changes up to 4 years.
  • Factors associated with greater adiposity gain included younger age at transplant (6-12 years), female sex, Black race, Hispanic ethnicity, and lower baseline BMI%.
  • Reduced corticosteroid use correlated with smaller BMI% increases.

Conclusions:

  • Most children show early, persistent increases in BMI% after renal transplantation, irrespective of baseline BMI%.
  • Early identification of at-risk children can inform targeted interventions.
  • Further research into optimizing immunosuppression to mitigate adiposity is warranted.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...